Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.23)
# 428
Out of 5,090 analysts
97
Total ratings
36.84%
Success rate
28.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.73 | +2.73% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $6.62 | +179.46% | 3 | Nov 6, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $3 → $2 | $0.65 | +207.69% | 13 | Nov 3, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $24 | $21.45 | +11.89% | 13 | Oct 31, 2025 | |
| NVAX Novavax | Maintains: Buy | $10 → $11 | $6.91 | +59.19% | 2 | Oct 23, 2025 | |
| DWTX Dogwood Therapeutics | Maintains: Buy | $10 → $12 | $6.00 | +100.04% | 2 | Sep 30, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.34 | +371.98% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $0.96 | +316.62% | 10 | Sep 3, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $1.04 | +380.77% | 6 | Aug 12, 2025 | |
| KZIA Kazia Therapeutics | Maintains: Buy | $2 → $13 | $15.05 | -13.62% | 5 | Jul 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $10.36 | +35.14% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $80.38 | -50.24% | 10 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $8.81 | +24.86% | 3 | Mar 26, 2025 |
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.73
Upside: +2.73%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $6.62
Upside: +179.46%
Plus Therapeutics
Nov 3, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.65
Upside: +207.69%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $21.45
Upside: +11.89%
Novavax
Oct 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $6.91
Upside: +59.19%
Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $6.00
Upside: +100.04%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.34
Upside: +371.98%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $0.96
Upside: +316.62%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $1.04
Upside: +380.77%
Kazia Therapeutics
Jul 10, 2025
Maintains: Buy
Price Target: $2 → $13
Current: $15.05
Upside: -13.62%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $10.36
Upside: +35.14%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $80.38
Upside: -50.24%
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $8.81
Upside: +24.86%